Last reviewed · How we verify
bOPV and IPV
bOPV and IPV is a Biologic drug developed by Aga Khan University. It is currently FDA-approved.
bOPV and IPV are types of vaccines used to prevent polio and other diseases such as diphtheria, tetanus, and pertussis, as well as measles, mumps, and rubella. They are administered through a vaccination schedule that may include sIPV and wIPV, and are classified as small molecule interventions.
At a glance
| Generic name | bOPV and IPV |
|---|---|
| Sponsor | Aga Khan University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand (PHASE3)
- Study of Concomitant Administration of the sIPV and DTaP or MMR (PHASE4)
- Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants (PHASE3)
- A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants (PHASE3)
- Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) (PHASE4)
- A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 (PHASE4)
- A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine (PHASE2)
- Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bOPV and IPV CI brief — competitive landscape report
- bOPV and IPV updates RSS · CI watch RSS
- Aga Khan University portfolio CI
Frequently asked questions about bOPV and IPV
What is bOPV and IPV?
Who makes bOPV and IPV?
What development phase is bOPV and IPV in?
Related
- Manufacturer: Aga Khan University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing